In SCLC, MYC activated Notch to dedifferentiate neuroendocrine (NE) tumor cells and promoted the temporal evolution of SCLC from ASCL1+ state to NEUROD1+ state to YAP1+ state (64). The gene discussed is ASCL1; the disease is small cell lung carcinoma.